| Full Name | Renova Pt Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 525 Calico Rd, Afton, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164291688 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Milton De Brun |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720351034 PECOS PAC ID: 7113323122 Enrollment ID: I20240208003743 |
News Archive
McMaster University researchers have found there is such a thing as too much oxygen for acutely ill adults.
A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.
Cephalon, Inc. confirmed today that it received an unsolicited proposal from Valeant Pharmaceuticals International, Inc., on March 18th to acquire the Company for $73 per share and a second unsolicited proposal on March 25th to either acquire the Company for $73 per share or to purchase Cephalon's non-oncology related assets for $2.8 billion. On March 29th, Valeant announced an unsolicited proposal to acquire all of the outstanding shares in the Company for $73 per share.
Two drugs already on the market - an antifungal and a steroid - may potentially take on new roles as treatments for multiple sclerosis. According to a study published in Nature today, researchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis.
A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.
› Verified 7 days ago
| Provider Name | Lissie Mayer |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1417220740 PECOS PAC ID: 6800231788 Enrollment ID: I20240301000944 |
News Archive
McMaster University researchers have found there is such a thing as too much oxygen for acutely ill adults.
A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.
Cephalon, Inc. confirmed today that it received an unsolicited proposal from Valeant Pharmaceuticals International, Inc., on March 18th to acquire the Company for $73 per share and a second unsolicited proposal on March 25th to either acquire the Company for $73 per share or to purchase Cephalon's non-oncology related assets for $2.8 billion. On March 29th, Valeant announced an unsolicited proposal to acquire all of the outstanding shares in the Company for $73 per share.
Two drugs already on the market - an antifungal and a steroid - may potentially take on new roles as treatments for multiple sclerosis. According to a study published in Nature today, researchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis.
A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Renova Pt Llc 1113 Tusculum Blvd # 104, Greeneville, TN 37745-4038 Ph: () - | Renova Pt Llc 525 Calico Rd, Afton, TN 37616-6631 Ph: (423) 788-5106 |
News Archive
McMaster University researchers have found there is such a thing as too much oxygen for acutely ill adults.
A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.
Cephalon, Inc. confirmed today that it received an unsolicited proposal from Valeant Pharmaceuticals International, Inc., on March 18th to acquire the Company for $73 per share and a second unsolicited proposal on March 25th to either acquire the Company for $73 per share or to purchase Cephalon's non-oncology related assets for $2.8 billion. On March 29th, Valeant announced an unsolicited proposal to acquire all of the outstanding shares in the Company for $73 per share.
Two drugs already on the market - an antifungal and a steroid - may potentially take on new roles as treatments for multiple sclerosis. According to a study published in Nature today, researchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis.
A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.
› Verified 7 days ago
Dr. Milton De Brun, D.P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 525 Calico Rd, Afton, TN 37616 Phone: 404-797-5058 |